Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122821) titled 'Doxycycline Prophylaxis to Reduce the Incidence of Bacterial Sexually Transmitted Infections in High-Risk Women: A Multicenter, Randomized Controlled Trials' on April 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Dematology Hospital of Southern Medical University
Condition:
Syphilis, Gonorrhea, Chlamydia
Intervention:
Standard Care Group:Receive standard prevention services provided in Guangdong Province (including free condoms and standard sexually transmitted infection education materials), without doxycycline.
Event-Driven Doxy-PEP Group:Oral doxycycline 200 mg within 72 ...